Medicare Part D coverage · levetiracetam · RxCUI 1736048
levetiracetam 500 MG Tablet for Oral Suspension
Per the CMS 2026 Part D formulary file, levetiracetam 500 MG Tablet for Oral Suspension is covered by 4,540 Medicare Part D plans (89.9% of enrollable products), averaging Tier 3.2, with prior authorization required on 6.5% of covering formularies.
- 89.9%
- Plan coverage
- 4,540
- Plans covering
- T3.2
- Avg tier
- 6.5%
- Prior auth required
What the CMS Formulary Data Shows for levetiracetam 500 MG Tablet for Oral Suspension
Per the CMS 2026 Part D formulary file, levetiracetam 500 MG Tablet for Oral Suspension (RxNorm concept RXCUI 1736048, generic name levetiracetam) appears on 232 distinct formulary files spanning 4,540 Medicare Part D plan offerings - 89.9% of enrollable Part D products, near-universal placement. Tier placement ranges from Tier 1 to Tier 4, with a cross-plan average of Tier 3.2.
Real-world access to levetiracetam 500 MG Tablet for Oral Suspension depends on utilization management as much as tier placement: 6.5% of covering formularies require prior authorization. 31.9% require step therapy. 47% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 766,583 Part D beneficiaries filled levetiracetam 500 MG Tablet for Oral Suspension in 2023, with total plan-and-beneficiary spending of $170,963,439 and an average per-beneficiary annual cost of $223.02. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry levetiracetam 500 MG Tablet for Oral Suspension today.
Coverage Details
- Formularies covering
- 232
- Plans covering
- 4,540
- Coverage rate
- 89.9%
- Tier range
- Tier 1 – Tier 4
- Average tier
- Tier 3, Preferred Brand
Restrictions
- Prior authorization required
- 6.5% of formularies
- Step therapy required
- 31.9% of formularies
- Quantity limits
- 47% of formularies
2023 Medicare Spending
- Beneficiaries
- 766,583
- Total spending
- $170,963,439
- Avg per beneficiary
- $223.02
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering levetiracetam 500 MG Tablet for Oral Suspension
100 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| Florida Complete Care-Duals VIP (HMO-POS D-SNP) | Hpmp OF Florida, Inc. | T1 | No | $0 | FL |
| ElderServe MAP (HMO D-SNP) | Elderserve Health, Inc. | T1 | No | $0 | NY |
| Cooperative Advantage (HMO D-SNP) | Group Health Cooperative OF EAU Claire | T1 | No | $0 | WI |
| Longevity Health Plan (PPO I-SNP) | Longevity Health Plan OF NEW Jersey Insurance Comp | T1 | No | $0 | NJ |
| Mercy Care Advantage (HMO D-SNP) | Mercy Care | T1 | No | $0 | AZ |
| Mercy Care Advantage (HMO D-SNP) | Mercy Care | T1 | No | $0 | AZ |
| Mercy Care Advantage (HMO D-SNP) | Mercy Care | T1 | No | $0 | AZ |
| Elderplan Plus Long-Term Care (HMO-POS D-SNP) | Elderplan, Inc. | T1 | No | $0 | NY |
| Health Choice Pathway (HMO D-SNP) | Health Choice Arizona, Inc. | T1 | No | $0 | AZ |
| Healthfirst CompleteCare (HMO D-SNP) | Healthfirst Health Plan, Inc. | T1 | No | $0 | NY |
| IMCare Classic (HMO D-SNP) | Itasca Medical Care | T1 | No | $0 | MN |
| Johns Hopkins Advantage MD D-SNP (HMO D-SNP) | Hopkins Health Advantage, Inc. | T1 | No | $0 | MD |
| MetroPlus UltraCare (HMO D-SNP) | Metroplus Health Plan, Inc. | T1 | No | $0 | NY |
| Upper Peninsula Health Plan MI Coordinated Health (HMO D-SNP) | Upper Peninsula Health Plan, LLC | T1 | No | $0 | MI |
| CareSource Dual Advantage (HMO D-SNP) | Caresource Georgia Co. | T1 | No | $0 | GA |
| Senior Whole Health SCO (HMO D-SNP) | Senior Whole Health, LLC | T1 | No | $0 | MA |
| Senior Whole Health SCO NHC (HMO D-SNP) | Senior Whole Health, LLC | T1 | No | $0 | MA |
| Molina One Care (HMO D-SNP) | Senior Whole Health, LLC | T1 | No | $0 | MA |
| HAP CareSource MI Coordinated Health (HMO D-SNP) | HAP Caresource | T1 | No | $0 | MI |
| CareAdvantage (HMO D-SNP) | SAN Mateo Health Commission | T1 | No | $0 | CA |
Show the next 30 plans
| NaviCare (HMO D-SNP) | Fallon Community Health Plan | T1 | No | $0 | MA |
| SeniorCare Complete (HMO D-SNP) | South Country Health Alliance | T1 | No | $0 | MN |
| AbilityCare (HMO D-SNP) | South Country Health Alliance | T1 | No | $0 | MN |
| Alameda Alliance Wellness (HMO D-SNP) | Alameda Alliance FOR Health | T1 | No | $0 | CA |
| CCA One Care (HMO D-SNP) | Commonwealth Care Alliance, Inc. | T1 | No | $0 | MA |
| CCA Senior Care Options (HMO D-SNP) | Commonwealth Care Alliance, Inc. | T1 | No | $0 | MA |
| Elevate Medicare Choice (HMO D-SNP) | Denver Health Medical Plan, Inc. | T1 | No | $0 | CO |
| AllCare Advantage Redwood Rx (HMO D-SNP) | Allcare Health Plan, Inc. | T1 | No | $0 | OR |
| PrimeWest Senior Health Complete (HMO D-SNP) | Primewest Rural MN Health Care Access Initiative | T1 | No | $0 | MN |
| Prime Health Complete (HMO D-SNP) | Primewest Rural MN Health Care Access Initiative | T1 | No | $0 | MN |
| Alterwood Advantage Dual Secure (HMO D-SNP) | Alterwood Advantage, Inc. | T1 | No | $0 | MD |
| Nascentia Dual Advantage (HMO D-SNP) | Visiting Nurse Association OF Central NEW York | T1 | No | $0 | NY |
| Provider Partners Pennsylvania Community Plan (HMO I-SNP) | Provider Partners Health Plan OF Pennsylvania, Inc | T1 | No | $0 | PA |
| Provider Partners North Carolina Community Plan (HMO I-SNP) | Provider Partners Health Plan OF North Carolina | T1 | No | $0 | NC |
| Provider Partners Indiana Community Plan (HMO I-SNP) | Provider Partners Health Plan OF Indiana | T1 | No | $0 | IN |
| Provider Partners Missouri Community Plan (HMO I-SNP) | Provider Partners Health Plan OF Missouri, Inc. | T1 | No | $0 | MO |
| Abilis Health Community (HMO I-SNP) | Signature Advantage, LLC | T1 | No | $0 | KY, TN |
| Arkansas Integrated Providers (AIP) Dual Advantage (HMO D-SNP) | Arkansas Superior Select, Inc. | T1 | No | $0 | AR |
| CalOptima Health OneCare Complete (HMO D-SNP) | Orange County Health Authority | T1 | No | $0 | CA |
| Mass General Brigham SCO (HMO D-SNP) | Mass General Brigham Health Plan, Inc | T1 | No | $0 | MA |
| Mass General Brigham One Care (HMO D-SNP) | Mass General Brigham Health Plan, Inc | T1 | No | $0 | MA |
| Tufts Health One Care (HMO D-SNP) | Tufts Health Public Plans, Inc. | T1 | No | $0 | MA |
| Tufts Health One Care CW (HMO D-SNP) | Tufts Health Public Plans, Inc. | T1 | No | $0 | MA |
| Tufts Health Plan Senior Care Options (HMO D-SNP) | Tufts Associated Health Maintenance Organization | T1 | No | $0 | MA |
| Tufts Health Plan Senior Care Options CW (HMO D-SNP) | Tufts Associated Health Maintenance Organization | T1 | No | $0 | MA |
| Leon MediExtra (HMO) | Leon Health, Inc. | T1 | No | $0 | FL |
| Leon MediDual (HMO D-SNP) | Leon Health, Inc. | T1 | No | $0 | FL |
| Leon MediMore (HMO) | Leon Health, Inc. | T1 | No | $0 | FL |
| Leon MediMax (HMO D-SNP) | Leon Health, Inc. | T1 | No | $0 | FL |
| Florida Complete Care (HMO I-SNP) | Hpmp OF Florida, Inc. | T1 | No | $4.80 | FL |
Showing top 50 of 100 plans.
Frequently Asked Questions
Is levetiracetam 500 MG Tablet for Oral Suspension covered by Medicare Part D?
Yes, levetiracetam 500 MG Tablet for Oral Suspension is covered by 4,540 Medicare Part D plans (89.9% of all Part D formularies).
What tier is levetiracetam 500 MG Tablet for Oral Suspension on Medicare Part D plans?
levetiracetam 500 MG Tablet for Oral Suspension averages Tier 3.2 across Part D plans, ranging from Tier 1 to Tier 4.
Does levetiracetam 500 MG Tablet for Oral Suspension require prior authorization?
6.5% of Part D formularies require prior authorization for levetiracetam 500 MG Tablet for Oral Suspension. Step therapy: 31.9%. Quantity limits: 47%.
How much does Medicare spend on levetiracetam 500 MG Tablet for Oral Suspension?
In 2023, total Medicare Part D spending on levetiracetam 500 MG Tablet for Oral Suspension was $170,963,439, covering 766,583 beneficiaries. The average spend per beneficiary was $223.02.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.
Closest average formulary tier
- caspofungin acetate 50 MG Injection T3.2
- alanine 8.8 MG/ML / arginine 4.89 MG/ML / glucose 100 MG/ML / glycine 4.38 MG/ML / histidine 2.04 MG/ML / isoleucine 2.55 MG/ML / leucine 3.11 MG/ML / lysine 2.47 MG/ML / methionine 1.7 MG/ML / phenylalanine 2.38 MG/ML / proline 2.89 MG/ML / serine 2.13 MG/ML / threonine 1.79 MG/ML / tryptophan 0.77 MG/ML / tyrosine 0.17 MG/ML / valine 2.47 MG/ML Injectable Solution [Clinimix 4.25/10] T3.2
- 0.5 ML ustekinumab-aekn 90 MG/ML Prefilled Syringe T3.2
- levonorgestrel 0.000583 MG/HR Intrauterine System [Skyla] T3.2
- 24 HR hydromorphone hydrochloride 12 MG Extended Release Oral Tablet T3.2
- clobetasol propionate 0.5 MG/ML Medicated Shampoo [Clodan] T3.2
Similar prior-authorization rate
- alprazolam 1 MG Oral Tablet 6.5% PA
- acyclovir 50 MG/ML Topical Cream 6.5% PA
- polymyxin B 250000 UNT/ML Injectable Solution 6.5% PA
- 0.88 ML paliperidone palmitate 310 MG/ML Prefilled Syringe [Invega] 6.4% PA
- 1.32 ML paliperidone palmitate 311 MG/ML Prefilled Syringe [Invega] 6.4% PA
- 1.75 ML paliperidone palmitate 312 MG/ML Prefilled Syringe [Invega] 6.4% PA